Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice (Q79616020)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 December 2006

Language	Label	Description	Also known as
English	Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice	scientific article published on 13 December 2006

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

author name string

Daniel Cláudio de Oliveira Gomes

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Eduardo Fonseca Pinto

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Luiz Dione Barbosa de Melo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Wallace Pacienza Lima

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Vicente Larraga

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ulisses Gazos Lopes

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Bartira Rossi-Bergmann

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

13 December 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

2168-2172

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Assessment of an optimized dog-culling program in the dynamics of canine Leishmania transmission.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Recent advances in vaccines for leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Expression cloning of a protective Leishmania antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Pretreatment of leishmania homologue of receptors for activated C kinase (LACK) promotes disease progression caused by Leishmania amazonensis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

DNA vaccines induce partial protection against Leishmania mexicana

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-γ production but does not protect BALB/c mice against Leishmania chagasi intravenous challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Mucosal immunity and tolerance: relevance to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generati

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Priming by microbial antigens from the intestinal flora determines the ability of CD4+ T cells to rapidly secrete IL-4 in BALB/c mice infected with Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.060

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.11.060

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240003%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79616020&oldid=1750400760"